Evidence map›Paper›PMID 34647211›Full record

ArticleEnvironmental science and pollution research international2022

Norfloxacin and gentamicin degradation catalyzed by manganese porphyrins under mild conditions: the importance of toxicity assessment.

Lucilaine Valéria de Souza Santos, Yuri Abner Rocha Lebron, Victor Rezende Moreira, Raquel Sampaio Jacob, Dayse Carvalho da Silva Martins, Lisete Celina Lange

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lucilaine Valéria de Souza SantosDepartment of Sanitary and Environmental Engineering, Universidade Federal de Minas Gerais, P.O. Box 1294, Belo Horizonte, MG, 30270-901, Brazil. lucilainevaleria@yahoo.com.br.
Yuri Abner Rocha LebronDepartment of Sanitary and Environmental Engineering, Universidade Federal de Minas Gerais, P.O. Box 1294, Belo Horizonte, MG, 30270-901, Brazil.
Victor Rezende MoreiraDepartment of Sanitary and Environmental Engineering, Universidade Federal de Minas Gerais, P.O. Box 1294, Belo Horizonte, MG, 30270-901, Brazil.
Raquel Sampaio JacobDepartment of Civil Engineering, Pontifícia Universidade Católica de Minas Gerais, P.O. Box 1686, Belo Horizonte, MG, 30535-901, Brazil.
Dayse Carvalho da Silva MartinsDepartment of Chemistry, Universidade Federal de Minas Gerais, P.O. Box 1294, Belo Horizonte, MG, 30270-901, Brazil.
Lisete Celina LangeDepartment of Sanitary and Environmental Engineering, Universidade Federal de Minas Gerais, P.O. Box 1294, Belo Horizonte, MG, 30270-901, Brazil.
Universidade Federal de Minas Gerais · BRPontifícia Universidade Católica de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current work assessed the degradation degree and the degradation products derived from norfloxacin (NOR) and gentamicin (GEN) using iodosylbenzene and iodobenzene diacetate, in the presence of manganese porphyrin as catalysts. Better results for NOR degradation (> 80%) were obtained when more hydrophobic porphyrins were employed. β-brominated manganese porphyrins showed a lower GEN degradation (~ 25%) than the non-brominated ones (~ 35%), probably due to their steric hindrance. In any case, complete mineralization was achieved neither for NOR nor for GEN, and the assignment of the generated products, complemented by the study of their toxicity, was an important step performed. From the obtained results, no correlation was found between the number of identified products and the reported toxicity value (r

Indexed as

ManganesePorphyrinsCatalysisGentamicinsNorfloxacinOxidation-ReductionGentamicinsManganeseNorfloxacinPorphyrinsAntibioticsBiomimetic systemCYP450PorphyrinsTransformation products

Identifiers

PMID34647211
OpenAlexW3206485163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.